Supportive therapy in neuro-oncology

Area of Science:

• Neuro-oncology
• Palliative Care
• Pharmacology

Background:

• Cerebral neoplasms (brain tumors) frequently cause non-malignant symptoms like pain.
• These symptoms complicate treatment and reduce patient quality of life.
• Supportive therapies, distinct from curative treatments, manage these associated disturbances.

Purpose of the Study:

• To examine frequently used drugs for supportive therapy in neuro-oncologic patients.
• To highlight the importance of supportive care in improving patient outcomes.
• To emphasize a patient-centered approach in neuro-oncologic care.

Main Methods:

• Review of common supportive medications used in neuro-oncology.
• Discussion of the impact of supportive therapies on quality of life and survival.
• Analysis of patient-centered care principles in neuro-oncology.

Main Results:

• Supportive therapies significantly enhance the quality of life for neuro-oncologic patients.
• Effective symptom management through supportive care can potentially increase patient survival rates.
• The study underscores the critical role of these interventions in holistic patient management.

Conclusions:

• Supportive therapies are indispensable in neuro-oncology, directly impacting patient well-being and longevity.
• Integrating specialized input and active listening to patient priorities is key to optimal supportive care.
• A holistic, person-patient-centered approach ensures better assistance and care for individuals with brain tumors.